Advanced Thyroid Cancer
Showing 9976 - 10000 of >10,000
Cancer Trial in Worldwide (Darolutamide (Nubeqa, BAY1841788))
Recruiting
- Cancer
- Darolutamide (Nubeqa, BAY1841788)
-
Homewood, Alabama
- +335 more
Aug 8, 2022
Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, Myelodysplastic Syndrome Trial in Houston (INCB018424)
Completed
- Acute Myeloid Leukemia
- +3 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Feb 5, 2020
LIFE - Lung Cancer, Immunotherapy, Frailty, Effect
Active, not recruiting
- Non-small Cell Lung Cancer
- +3 more
- CT-scans extended
- +3 more
-
Odense, DenmarkDepartment of Oncology, Odense University Hospital
May 17, 2022
Breast Cancer, Infertility Trial in New York (Letrozole)
Completed
- Breast Cancer
- Infertility
-
New York, New YorkWeill Cornell Medical College
Nov 18, 2022
Patients With Advanced Solid Tumor (Excluding NSCLC, SCLC, and Mesothelioma) With Results From a Multi-gene Next-generation
Not yet recruiting
- Patients With Advanced Solid Tumor (Excluding NSCLC, SCLC, and Mesothelioma) With Results From a Multi-gene Next-generation Sequencing (NGS) Panel (>30 Genes)
- Minimal documentation
- Extended documentation
-
Mannheim, Baden-Württemberg, Germany
- +1 more
Jan 18, 2023
Metastatic Breast Cancer, Tumor, Muscle Tumors Trial in Colorado Springs (Method(s)1 Attribution, Method(s)2 Attribution,)
Not yet recruiting
- Metastatic Breast Cancer
- +3 more
- Method(s)1 Attribution
- Method(s)2 Attribution,
-
Colorado Springs, ColoradoPNAF Medical
Nov 23, 2023
Diagnosis and Clinical Management of Angiogenic Breast Cancer Trial in Chandigarh, New Delhi, Johannesburg (Ga-68-PEG-?vß3-IAC
Not yet recruiting
- Diagnosis and Clinical Management of Angiogenic Breast Cancer
- Ga-68-PEG-Αvβ3-IAC PET/CT
-
Chandigarh, India
- +2 more
May 27, 2022
Advances in Imaging to Assess Response in Pancreatic Cancer
Recruiting
- Pancreatic Ductal Adenocarcinoma
-
Glasgow, United KingdomBeatson West of Scotland Cancer Centre
Feb 3, 2023
Palliative Care Trial (Short course radiotherapy)
Completed
- Palliative Care
- Short course radiotherapy
- (no location specified)
Sep 12, 2019
Gastrointestinal Stromal Tumors Trial in Changsha (Apatinib Mesylate, Sunitinib, Imatinib dosage, Dasatinib, Reveratinib)
Recruiting
- Gastrointestinal Stromal Tumors
- Apatinib Mesylate
- Sunitinib, Imatinib dosage, Dasatinib, Reveratinib
-
Changsha, Hunan, ChinaXiangya Hospital, Central South University
Mar 1, 2023
Rectal Adenocarcinoma, Stage II Rectal Cancer AJCC v8, Stage IIA Rectal Cancer AJCC v8 Trial in Houston (drug, other, procedure)
Not yet recruiting
- Rectal Adenocarcinoma
- +8 more
- Chemotherapy
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Feb 25, 2022
Mature B-cell Non-Hodgkin Lymphoma Trial in Chengdu (Prednisone,Vincristine, Cyclophosphamide, Cyclophosphamide, Vincristine,
Active, not recruiting
- Mature B-cell Non-Hodgkin Lymphoma
- Prednisone,Vincristine, Cyclophosphamide
- +5 more
-
Chengdu, Sichuan, ChinaWest China Second University Hospital of Sichuan University
Mar 17, 2022
Imaging FDG Flare in Melanoma
Completed
- Metastatic Melanoma
-
Philadelphia, PennsylvaniaAbramson Cancer Center of the University of Pennsylvania
Jul 7, 2020
Non-colorectal Cancer (Esophagus, Stomach, Liver/Bile Ducts, Pancreas, Neuroendocrine Carcinoma), Colorectal With Associated
Recruiting
- Non-colorectal Cancer (Esophagus, Stomach, Liver/Bile Ducts, Pancreas, Neuroendocrine Carcinoma)
- Colorectal With Associated Risk Factors
- multidisciplinary assessment and intervention
-
Paris, FranceInstitut Curie
Aug 26, 2021
Prostatic Tumors Trial in Winnipeg (Stereotactic body RT with MR-guided boost)
Terminated
- Prostatic Neoplasms
- Stereotactic body RT with MR-guided boost
-
Winnipeg, Manitoba, CanadaCancerCare Manitoba
Mar 4, 2022
Solid Tumor, Kidney Cancer Trial in Boston (pazopanib, everolimus)
Completed
- Solid Tumor
- Kidney Cancer
-
Boston, Massachusetts
- +1 more
Sep 18, 2019
Histologically or Cytologically Confirmed Pancreatic Ca, Unresectable or Borderline Resectable Pancreatic Ca Trial run by the
Completed
- Histologically or Cytologically Confirmed Pancreatic Ca
- Unresectable or Borderline Resectable Pancreatic Ca
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Nov 4, 2019
Hepatocellular Carcinoma Trial in Brussels (Radioembolization using Holmium-166)
Active, not recruiting
- Hepatocellular Carcinoma
- Radioembolization using Holmium-166
-
Brussels, Anderlecht, BelgiumHôpital Universitaire Erasme, ULB
Dec 7, 2022
Locally Advanced Cancer in the Anal Region Trial in Oslo, Lund, Uppsala (Cetuximab, Mitomycin C, 5-Fluoruracil)
Completed
- Locally Advanced Cancer in the Anal Region
- Cetuximab
- +3 more
-
Oslo, Norway
- +2 more
Feb 27, 2020
Pancreatic Cancer Non-resectable Trial in Louisville (Folfirinox, Stereotactic Body Radiation Therapy)
Recruiting
- Pancreatic Cancer Non-resectable
- Folfirinox
- Stereotactic Body Radiation Therapy
-
Louisville, Kentucky
- +1 more
Oct 24, 2019
Multiple Myeloma, MDS, Diffuse Large B Cell Lymphoma Trial in Denmark (Advance consultation concerning your life and treatment
Recruiting
- Multiple Myeloma
- +3 more
- Advance consultation concerning your life and treatment (ACT )
-
Aalborg, Denmark
- +6 more
Jan 31, 2023
Colorectal Cancer (CRC)
Recruiting
- Colorectal Neoplasms
- No intervention for this trial.
-
Scottsdale, Arizona
- +8 more
Aug 15, 2022